We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Forest Laboratories appoints executive team members

Forest Laboratories appoints executive team members

December 11, 2013
CenterWatch Staff

Forest Laboratories, a specialty pharmaceutical company focused on the U.S., has announced appointments to its executive leadership team as part of its plans to flatten and broaden the organization during Project Rejuvenate.

"We are announcing an important step to rejuvenate our company by creating the first Forest executive team with broad leadership responsibilities, a sharp focus and clear accountability for driving sustainable growth," said Brent Saunders, CEO and president Forest Laboratories.

Elaine Hochberg has been appointed executive vice president, international, strategic planning and government affairs. Bill Meury was appointed executive vice president, sales and marketing. Frank Perier, Jr., now is executive vice president, chief financial officer. Marco Taglietti, M.D., is executive vice president, drug R&D, and chief medical officer. Bob Bailey is senior vice president, chief legal officer, general counsel and corporate secretary. Alex Kelly has been appointed senior vice president, chief communications and investor relations officer. Sally Paull was appointed senior vice president, human resources. Kevin Walsh now is senior vice president, operations. Joe Zimmerman has been appointed senior vice president, chief compliance officer.

David Solomon, senior vice president, corporate development and strategic planning, will become senior advisor to the chief executive officer responsible for business development and alliance management on a transitional basis.

"Solomon played an instrumental role in driving and executing our company's successful Next 9 Strategy, which has given us a solid foundation of future growth drivers," said Saunders. "During his transition period, I will draw on David's experience and counsel as we embark on our company's next chapter."

The next step in Project Rejuvenate is for the Forest executive team to design and staff their respective teams in a manner consistent with the principles of flattening and broadening the organization.

Global News Awards & Advancement

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

  • China-360x240

    U.S. Tops List of Trial Startups With China Making Progress in Phase 1

  • Phoneapp-360x240

    Device Apps Present Unique Risks in Trials

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing